Danaher Corporation (DHR) Shares Sold by Mcmillion Capital Management Inc.
Mcmillion Capital Management Inc. cut its stake in shares of Danaher Corporation (NYSE:DHR) by 0.2% during the first quarter, Holdings Channel reports. The fund owned 22,086 shares of the conglomerate’s stock after selling 40 shares during the period. Mcmillion Capital Management Inc.’s holdings in Danaher Corporation were worth $1,889,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Israel Discount Bank of New York purchased a new position in Danaher Corporation during the first quarter valued at $209,000. DE Burlo Group Inc. increased its position in Danaher Corporation by 17.8% in the first quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock valued at $11,242,000 after buying an additional 19,900 shares during the last quarter. Exane Derivatives purchased a new position in Danaher Corporation during the first quarter valued at $838,000. Bronfman E.L. Rothschild L.P. increased its position in Danaher Corporation by 30.7% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 17,947 shares of the conglomerate’s stock valued at $1,535,000 after buying an additional 4,219 shares during the last quarter. Finally, Toronto Dominion Bank increased its position in Danaher Corporation by 52.5% in the first quarter. Toronto Dominion Bank now owns 177,994 shares of the conglomerate’s stock valued at $15,225,000 after buying an additional 61,239 shares during the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.
Danaher Corporation (NYSE:DHR) traded up 1.3697% during midday trading on Wednesday, hitting $81.6634. The stock had a trading volume of 1,015,596 shares. The stock has a market cap of $56.73 billion, a PE ratio of 26.0656 and a beta of 1.03. Danaher Corporation has a one year low of $75.71 and a one year high of $88.01. The firm has a 50 day moving average price of $82.61 and a 200 day moving average price of $84.26.
Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the business earned $0.90 EPS. The company’s revenue was up 6.3% on a year-over-year basis. Equities analysts expect that Danaher Corporation will post $3.95 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/16/danaher-corporation-dhr-shares-sold-by-mcmillion-capital-management-inc.html.
DHR has been the subject of several research analyst reports. Zacks Investment Research downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Deutsche Bank AG reissued a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research report on Wednesday, June 21st. BTIG Research reissued a “buy” rating and set a $92.00 price target on shares of Danaher Corporation in a research report on Sunday, April 23rd. Vetr raised Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 price target for the company in a research report on Thursday, April 20th. Finally, Wells Fargo & Company started coverage on Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $91.76.
In other Danaher Corporation news, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the sale, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Over the last three months, insiders have sold 38,623 shares of company stock worth $3,206,426. Company insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.